Abstract
Full Text Available
Keywords: DHA supplementation, cognitive decline, Alzheimers disease, herbal supplements
Current Alzheimer Research
Title: Memory Improvement with Docosahexaenoic Acid Study (MIDAS)-Brief Review
Volume: 4 Issue: 5
Author(s): Karin Yurko-Mauro
Affiliation:
Keywords: DHA supplementation, cognitive decline, Alzheimers disease, herbal supplements
Abstract: Full Text Available
Export Options
About this article
Cite this article as:
Yurko-Mauro Karin, Memory Improvement with Docosahexaenoic Acid Study (MIDAS)-Brief Review, Current Alzheimer Research 2007; 4 (5) . https://dx.doi.org/10.2174/156720507783018244
DOI https://dx.doi.org/10.2174/156720507783018244 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
All for Statins and Statins for All; An Update
Current Pharmaceutical Design High PIB Retention in Alzheimers Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters
Current Alzheimer Research Nitric Oxide and Schizophrenia: Present Knowledge and Emerging Concepts of Therapy
CNS & Neurological Disorders - Drug Targets Possible Targets of Herbals for Type 3 Diabetes: A Review
Current Traditional Medicine The Effect of First-in-Class Small Molecule RhoA Inhibitor, HL07, on the Phenylephrine-induced Artery Contraction
Current Pharmaceutical Design Bioinformatic Analysis of HIV-1 Entry and Pathogenesis
Current HIV Research The Nun Study: Risk Factors for Pathology and Clinical-Pathologic Correlations
Current Alzheimer Research Neural Stem Cell Niches in Health and Diseases
Current Pharmaceutical Design The Use of Microarrays to Characterize Neuropsychiatric Disorders: Postmortem Studies of Substance Abuse and Schizophrenia
Current Molecular Medicine Current and Potential Use of Citrus Essential Oils
Current Organic Chemistry On the Psychotropic Effects of Carbon Dioxide
Current Pharmaceutical Design Glia as a Turning Point in the Therapeutic Strategy of Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Biomarkers of Protein Oxidation in Human Disease
Current Molecular Medicine Anesthetic Neuroprotection: Antecedents and An Appraisal of Preclinical and Clinical Data Quality
Current Pharmaceutical Design Mitotic and Gender Parallels in Alzheimer Disease: Therapeutic Opportunities
Current Drug Targets Vitamins Mediate Immunological Homeostasis and Diseases at the Surface of the Body
Endocrine, Metabolic & Immune Disorders - Drug Targets Antiviral Activities of Pyridine Fused and Pyridine Containing Heterocycles, A Review (from 2000 to 2020)
Mini-Reviews in Medicinal Chemistry Anticoagulant Therapy in Very Old Patients
Cardiovascular & Hematological Disorders-Drug Targets Inflammation and Chronic Heart Failure: From Biomarkers to Novel Anti-inflammatory Therapeutic Strategies
Medicinal Chemistry Cellular Protection and Therapeutic Potential of Tocotrienols
Current Pharmaceutical Design